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Introduction:The efficacy of screening and brief interventions (SBIs) for excessive alcohol
use in primary care is well established; however, evidence on their cost-effectiveness is
limited. A small number of previous reviews have concluded that SBI programs are likely
to be cost-effective but these results are equivocal and important questions around the
cost-effectiveness implications of key policy decisions such as staffing choices for delivery
of SBIs and the intervention duration remain unanswered.
Methods:Studies reporting both the costs and a measure of health outcomes of programs
combining SBIs in primary care were identified by searching MEDLINE, EMBASE, Econlit,
the Cochrane Library Database (including NHS EED), CINAHL, PsycINFO, Assia and the
Social Science Citation Index, and Science Citation Index via Web of Knowledge. Included
studies have been stratified both by delivery staff and intervention duration and assessed
for quality using the Drummond checklist for economic evaluations.
Results:The search yielded a total of 23 papers reporting the results of 22 distinct studies.
There was significant heterogeneity in methods and outcome measures between stud-
ies; however, almost all studies reported SBI programs to be cost-effective. There was no
clear evidence that either the duration of the intervention or the delivery staff used had a
substantial impact on this result.
Conclusion:This review provides strong evidence that SBI programs in primary care are a
cost-effective option for tackling alcohol misuse.
Keywords: alcohol drinking, screening and brief intervention, primary care, systematic review, policy making,
resource allocation, brief alcohol intervention, brief intervention
INTRODUCTION
The misuse of alcohol is a substantial concern for public health
policy makers across the world, with over 5% of the global burden
of disease and injury estimated as being alcohol-attributable (1).
In addition to these deleterious effects on health and the associated
economic costs, excessive consumption of alcohol is also associ-
ated with a range of social harms such as increased crime, public
nuisance, and reduced workplace productivity, which impact not
just on the drinker, but on society as a whole (2).
Primary care provides an avenue through which a large propor-
tion of the population can be reached by interventions aimed at
reducing alcohol misuse and the related consequences. In particu-
lar, excessive drinkers attend primary care with greater frequency
than moderate drinkers (3) and may therefore be more easily
targeted through this channel. Programs of Screening and Brief
Interventions (SBIs), in which patients are screened opportunisti-
cally for alcohol misuse and those screening positively are offered
a brief session of advice can harness these properties to achieve
broad coverage of the population at risk (4).
There is a substantial body of existing research into the effec-
tiveness of SBI programs in primary care, with a recent review of
reviews identifying 24 previous systematic reviews (5). The con-
sistent finding of these studies is that SBIs are effective at reducing
excessive alcohol consumption and this weight of evidence has
led to the inclusion of SBIs in a range of international policy rec-
ommendations including the World Health Organisation’s global
strategy for tackling harmful alcohol use (6). However, in spite of
these calls for the implementation of such policies, evidence on
the cost-effectiveness of SBI programs is less equivocal. This is a
key question for the policy makers and healthcare budget planners
being urged to instigate or fund these programs and there have
been few attempts to draw together the existing literature in order
to inform their decisions.
There have been three major previous reviews of the cost-
effectiveness evidence on SBIs in primary care (7–9). While all
three conclude that they are cost-effective, none examine the
impact that implementation decisions such as the staff used to
deliver the SBI, or the duration of the intervention itself, have
on overall program cost-effectiveness. These issues are critical
as the use of general practitioners (GPs) to deliver SBIs is usu-
ally a substantially more expensive option than nursing staff and
a lack of available time is the single greatest perceived barrier
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to early intervention in alcohol problems in primary care (10).
In addition, these existing reviews either predate several impor-
tant studies or have a narrow scope which misses a number of
key papers. This study updates and expands the 2008 review
by Latimer et al. (8) in order to provide a systematic overview
of the existing cost-effectiveness evidence for SBIs in primary
care, together with an examination of the differential impact of
alternative implementation options.
METHODS
The original search was undertaken in May 2008 (8) and refreshed
on four subsequent occasions, with the latest update undertaken
in April 2014. Searches were conducted on the following electronic
databases:
Medline in Process and Other Non-Indexed Citations and
Medline 1950-present via OVID SP
EMBASE via OVID SP
Science Citation Index via Web of Knowledge
Social Science Citation Index via Web of Knowledge
Cochrane Library Databases via Wiley
Assia via CSA
PsycINFO via OVID SP
Econlit via OVID SP
The original search undertaken in 2008 adopted an iterative
emergent approach. Rather than developing an a priori search
strategy, smaller individual searches were undertaken in order
to develop understanding of the research area. The information
specialist (Louise Preston) and lead reviewer (Nicholas Latimer)
worked together to develop further iterations of the search strat-
egy based on the findings of earlier searches. As a result, for this
update, the use of a predetermined search strategy was possible as
search terms had been tested and validated as part of the original
searches. The search strategy is presented in Figure 1.
The title and abstracts of all retrieved studies were screened
by one reviewer (Colin Angus) against a set of pre-defined inclu-
sion and exclusion criteria. These criteria, listed in Supplementary
Material, were piloted with a second reviewer (Jessica Li) on an
initial subsample of 10 studies and subsequently refined, follow-
ing discussions between both reviewers, to ensure clarity in their
interpretation. Any study reporting the costs and health or other
economic benefits of SBI programs in primary care were consid-
ered for inclusion. Studies were excluded which were not published
in English, which examined multi-behavior interventions (e.g.,
combined drink and drugs education programs), which included
components occurring outside of primary care, or which evalu-
ated interventions comprising more than four patient contacts (on
the grounds that these no longer constitute “brief” interventions).
Studies examining SBI implementation strategies only (e.g., GP
education programs to increase delivery rates of SBIs to patients)
were excluded unless they presented a separate economic evalua-
tion of the SBI delivery itself. Similarly, studies that examined only
screening tools (e.g., AUDIT or CAGE) were excluded unless they
also included a BI component.
Data from all included studies were extracted by one reviewer
(Colin Angus) using a standard template (see Supplementary
INTERVENTION And PROBLEM
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FIGURE 1 | Search strategy utilized in the review.
Material) adapted from that used by Latimer et al. (8). Studies
were assessed for methodological quality using the Drummond
checklist for economic evaluations (11) as recommended for use
in Cochrane reviews (12). Five of the included studies were ran-
domly selected and additionally assessed for quality by a second
reviewer (Jessica Li) to ensure consistency (agreement was 100%
between both reviewers).
RESULTS
Twenty-three papers reporting the results of 22 distinct studies
that met the criteria for inclusion in the review were identi-
fied. These fall into two major categories: economic evaluations
alongside clinical trials (EEACTs) (13–21) and stand-alone mod-
eling evaluations (4, 7, 22–33). Table 1 summarizes these studies,
while excluded studies are reported in Supplementary Mater-
ial. A glossary of relevant health economic terms is included in
Supplementary Material.
These 23 studies examine the cost-effectiveness of SBIs in
almost exclusively high-income countries (Chisholm et al. being
the only exception (30)), with the majority of studies covering the
USA (8 studies), UK (5 studies), or Australia (3 studies). There
was considerable variation in the quality of the studies, with 7
rated as being of low quality, 10 of moderate quality, and 5 of high
quality, although there are signs of an improving trend over time
with more recent papers scoring more highly. The main issues
encountered were an inadequate description of the intervention
itself, poor reporting of the sources of cost data used in the studies,
and insufficient sensitivity analysis.
Of the nine studies reporting evaluations alongside clinical tri-
als, two compared different levels of brief intervention (13, 14),
both concluding that a longer “stepped care” intervention was the
most cost-effective option. Another six studies compared brief
interventions with usual care (15, 17–21). The trials that these
studies are associated with ran for between 6 and 48 months, while
the full effect of changes in drinking behavior on health outcomes
can take many years to develop (34). It is therefore perhaps unsur-
prising that these studies found few statistically significant results
and do not allow any firm conclusions to be drawn around the
cost-effectiveness of SBI programs.
All except one of the 14 modeling studies compared SBI pro-
vision to an alternative do-nothing scenario in which no SBIs are
delivered. The other study (24) examined the cost-effectiveness
of increasing the current uptake rate. Among these studies, the
most common health outcome measures were QALYs (4, 23, 25,
26, 28, 31, 33), with two studies using DALYs (22, 30) and two
using life years gained (7, 32). Almost all these studies found SBIs
to be either cost-saving and health improving (i.e., they dominate
a do-nothing scenario) or to have very low costs relative to health
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Table 1 | Characteristics of included studies.
Study Country Study
type
Comparators Costs included Health
outcomes
included
Results Quality Duration of
intervention
BI delivery
staff
Angus
et al. (28)
Italy CUA (1) Do-nothing scenario (2)
Screening with AUDIT-C followed
by 10 min brief intervention
Intervention costs and
health and social care
resource use over
30 years following start
of program
QALYs gained
over 30 years
follow-up
SBI delivered at next GP
registration has an ICER of C550
per QALY vs. do-nothing. SBI at
next GP consultation has an ICER
of C590 per QALY vs. do-nothing.
++ 10 min GP
Angus
et al. (33)
Netherlands
and Poland
CUA (1) Do-nothing scenario
(2) Screening with AUDIT-C
followed by 10 min brief
intervention
Intervention costs and
health and social care
resource use over
30 years following start
of program
QALYs gained
over 30 years
follow-up
Netherlands: SBI delivered at next
GP registration has an ICER of
C6340 per QALY vs. do-nothing.
SBI at next GP consultation has an
ICER of C5748 per QALY vs.
do-nothing. Poland: SBI delivered
at next GP registration has an
ICER of zł3696 per QALY vs.
do-nothing. SBI at next GP
consultation has an ICER of zł3269
per QALY vs. do-nothing.
++ 10 min GP
Babor
et al. (15)
USA EEACT/
CEA
Screening with AUDIT followed by
either: (1) Treatment as usual
(2) 3–5 min brief intervention
Intervention costs SF-12 score and
mean alcohol
consumption at
12 months
follow-up
Small but significant reduction in
consumption for BI group vs.
treatment as usual. No significant
difference in SF-12 scores. No
significant differences in either
outcome between GP- and
nurse-delivered intervention
groups
− 3–5 min GP or nurse
Chisholm
et al. (30)
International CUA (1) Do-nothing scenario
(2) Screening followed by brief
intervention involving four primary
care visits inside a year
Intervention costs DALYs averted
over a lifetime
horizon
SBI varies from dominated by to
dominating a do-nothing scenario
depending on WHO region with
9/12 regions having an ICER of
≤5000I$ per QALY
+ Not stated GP
Cobiac
et al. (22)
Australia CUA (1) Do-nothing scenario
(2) Screening followed by
counseling, supportive written
materials and follow-up
consultations with further advice
“if necessary”
Intervention costs,
patient time/travel and
health and social care
resource use over
lifetime horizon
DALYs averted
over a lifetime
horizon
ICER of $6800 per DALY averted
vs. do-nothing
− Not stated GP
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Table 1 | Continued
Study Country Study
type
Comparators Costs included Health
outcomes
included
Results Quality Duration of
intervention
BI delivery
staff
Dillie et al.
(16)
USA EEACT/
Cost
mini-
mization
analysis
Screening with self-reported
alcohol consumption followed by
either:
(1) 2×15 min brief interventions
each followed up with a 5 min
telephone call
(2) Additional screened with %
CDT followed by 2×15 min brief
interventions each followed up
with a 5 min telephone call
Intervention costs,
patient time/travel,
health and social care
resource use, motor
vehicle crashes and
legal/criminal costs over
4 years follow-up
N/A Addition of % CDT screening
saves $212 per patient screened
+ 40 min GP (nurse
delivers
follow-up
phone calls)
Drummond
et al. (14)
UK (Wales) EEACT/
CUA
Screening with AUDIT followed by
either:
(1) 5-min nurse-led “minimal
intervention”
(2) ”Stepped care” – 20 min
behavioral change counseling
session followed up with referral
to motivational enhancement
therapy and/or specialist alcohol
services if indicated
Intervention costs,
health and social care
resource use costs and
costs of crime at
6 months follow-up
QALYs gained at
6 months follow
up
Stepped care 98% likely to be
most cost-effective option at a
threshold of £20,000–30,000 per
QALY. No ICER presented
− 5 min
(minimal
intervention)
or 20+min
(stepped
care)
Practice
nurse
Fleming
et al. (17,
18)
USA EEACT/
CBA
Screening with 7-day timeline
follow back followed by either:
(1) Patient information leaflet
(2) 2×15 min brief interventions
each followed up with a 5 min
telephone call
Intervention costs,
patient time/travel,
health and social care
resource use, motor
vehicle crashes and
legal/criminal costs over
lifetime horizon
Mean alcohol
consumption at
various points up
to 4 years
follow-up
Significant reduction in
consumption observed in SBI
group (32% in men, 43% in
women). SBI estimated to save
$546 per patient from healthcare
perspective and $7780 from a
societal perspective vs. patient
information leaflet
+ 40 min GP (nurse
delivers
follow-up
phone calls)
Freeborn
et al. (19)
USA EEACT/
Resource
utiliza-
tion
analysis
Screening with AUDIT followed by
either:
(1) Treatment as usual
(2) Brief advice from GP then
15 min motivational session with
trained counselor
Health and social care
resource use over
2 years follow-up
N/A No significant difference in health
and social care resource use
between BI and care as usual
groups
− 15+min GP and
trained
counselor
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Table 1 | Continued
Study Country Study
type
Comparators Costs included Health
outcomes
included
Results Quality Duration of
intervention
BI delivery
staff
Freemantle
et al. (29)
International CEA (1) Do-nothing scenario
(2) Screening with AUDIT followed
by 15 min brief intervention
Intervention costs Mean alcohol
consumption at
24 months
follow-up
SBI costs £8–20 per patient,
which equates to £18–47 per
patient who reduces their
drinking, with a mean reduction of
24% among those who cut down
− 15 min GP
Kapoor
et al. (23)
USA CUA (1) Do-nothing scenario
(2) Screening with AUDIT followed
by full clinical assessment of
unhealthy alcohol use and
5–10 min brief intervention
(3) Screening with AUDIT and %
CDT followed by full clinical
assessment of unhealthy alcohol
use and 5–10 min brief
intervention
Intervention costs,
health and social care
resource use over
lifetime horizon
QALYs gained
over lifetime
horizon
Both screening strategies
dominate vs. do-nothing.
Incremental cost of adding % CDT
to screening is $15,500 per QALY
+ 5–10 min Not stated
Lock et al.
(20)
UK
(England)
EEACT/
Cost
mini-
mization
analysis
Screening with AUDIT followed by
either:
(1) Treatment as usual
(2) 5–10 min nurse-led brief
intervention
Intervention costs,
health and social care
resource use and
personal costs at
12 months follow-up
SF-12 score at
12 months
follow-up
No statistically significant
difference in costs or health
outcomes between arms
+ 5–10 min Nurse
Ludbrook
et al. (7)
UK
(Scotland)
CEA (1) Do-nothing scenario
(2) Screening using 7-day timeline
follow back followed by 2×15 min
brief interventions each followed
up with a 5 min telephone call
Intervention costs,
patient time/travel,
health and social care
resource use, motor
vehicle crashes and
legal/criminal costs over
lifetime horizon
Life years gained
over lifetime
horizon
SBI dominates vs. do-nothing − 40 min GP (nurse
delivers
follow-up
phone calls)
Mundt
et al. (21)
USA EEACT/
CBA
Screening with health screening
survey and assessment interview
followed by either:
(1) Treatment as usual
(2) 2×15 min bried interventions
each followed up with a 5 min
telephone call
Intervention costs,
patient time/travel and
health and social care
resource use over
2 years follow-up
Life years lost
(valued at
$50,000 each)
over 2 years
follow-up
Non-significant cost savings of
$467 from healthcare perspective
and $812 from societal
perspective for BI vs. treatment as
usual
+ 40 min GP (nurse
delivers
follow-up
phone calls)
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Table 1 | Continued
Study Country Study
type
Comparators Costs included Health
outcomes
included
Results Quality Duration of
intervention
BI delivery
staff
Navarro
et al. (24)
Australia CEA (1) Current level of SBI provision
(2) Increased levels of screening
and brief intervention or combined
SBI provision
Intervention costs
(including training)
Number of risky
drinkers who
reduce their
alcohol
consumption
Additional cost of between
$174–1041 per risky drinker who
reduces their drinking, depending
on the scenario
+ Not stated GP
Purshouse
et al. (4)
UK
(England)
CUA (1) Do-nothing scenario
(2) Screening with AUDIT followed
by 5 min brief intervention
Intervention costs and
health and social care
resource use over
30 years following start
of program
QALYs gained
over 30 years
follow-up
SBI delivered at next GP
registration dominates do-nothing
scenario. SBI at next GP
consultation has an ICER of £1175
per QALY vs. do-nothing
++ 5 min Practice
nurse/GP
(both
modeled)
Rehm
et al. (27)
Canada CBA (1) Do-nothing scenario
(2) Screening followed by brief
intervention
Health and social care
resource use costs,
costs of crime and
productivity losses due
to death and disability
per annum. Unclear if
intervention costs are
included
Deaths, years of
life lost and
acute hospital
days averted per
annum
Introduction of BI would avoid 360
deaths, 9000 years of life lost,
56,000 acute care hospital days
and would reduce
alcohol-attributable costs by
$602m per annum vs. do-nothing
+ Not stated Not stated
Saitz et al.
(31)
USA CUA (1) Do-nothing scenario
(2) Screening followed by brief
intervention
Intervention costs and
health and social care
resource use over
lifetime horizon
QALYs gained
over a lifetime
horizon
SBI dominates vs. do-nothing − Not stated Not stated
Solberg
et al. (25)
USA CUA (1) Do-nothing scenario
(2) Annual screening followed by
5 min BI
Intervention costs,
patient time/travel and
health and social care
resource use over
lifetime horizon
QALYs gained
over lifetime
horizon
ICER of $1750 per QALY vs.
do-nothing with healthcare
perspective. SBI dominates with
societal perspective
+ 5 min GP
Tariq et al.
(26)
Netherlands CUA (1) Do-nothing scenario
(2) Screening with AUDIT followed
by 10–15 min brief intervention
Intervention costs and
health and social care
resource use costs over
a lifetime horizon
QALYs gained
over lifetime
horizon
ICER of C5400 per QALY gained
for brief interventions vs.
do-nothing
++ 30–45 min GP
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gains, making SBI programs highly likely to be considered cost-
effective under the relevant national guidelines. The sole exception
was Chisholm et al. (30), who presented separate costs and bene-
fits for each of 12 World Health Organization (WHO) sub-regions
and found that SBI programs are dominated by current taxation
in parts of Africa (region AfrE), although they estimated that they
are either cost-effective or cost-saving in the remaining 11 sub-
regions using the WHO’s estimated cost-effectiveness thresholds
(35). Of the remaining modeling studies, one (27) uses a burden
of disease approach to estimate SBIs would be substantially cost-
saving (Canadian $602m per annum). The remaining studies (24,
29) use intermediate end points (number of risky drinkers averted
and change in mean alcohol consumption), which make the results
unhelpful for the purpose of informing resource allocation deci-
sions without additional modeling to estimate the impact of these
end points on health outcomes. The majority of these modeling
studies consider outcomes over a 30 year (4, 28, 33) or lifetime (7,
22, 23, 25, 26, 30, 31) time horizon, ensuring that the long-term
impacts are reflected in the results.
Fifteen studies examine the cost-effectiveness of GP-delivered
interventions (4, 7, 15, 16, 18, 21, 22, 24–26, 28–30, 32, 33), while
only five examine nurse-delivered interventions (4, 13–15, 20).
Owing to the substantial heterogeneity between studies both in
terms of methods and outcomes it is difficult to draw any clear
conclusions about the relative cost-effectiveness of using different
staff to deliver SBI programs, although the lack of a clear differ-
ence between the two options may be of interest to policy makers.
Only two studies directly compare both options: Purshouse et al.
(4) assume a priori that delivery staff do not impact on the effec-
tiveness of the BI but find that even the use of the more expensive
GP-delivered BI option is unlikely to prevent the program from
being cost-effective. Meanwhile, Babor et al. (15) conducted a
trial with separate nurse-delivered and GP-delivered SBI arms.
The authors found no significant difference in effectiveness of the
intervention between these arms, while the nurse-delivered option
was around 1/3 cheaper, indicating it to be a more cost-effective
option.
With regards to the total duration of the intervention (i.e., the
total contact time between patient and delivery staff, either face-
to-face or over the telephone, aggregated over multiple contacts
where appropriate), 12 studies evaluate interventions of 10 min or
less (4, 13–15, 20, 23, 25, 28, 32, 33) and 11 consider interventions
of over 10 min (with a maximum duration of 45 min) (4, 7, 13,
14, 16, 18, 21, 26, 28, 29). Again the heterogeneity of methods and
outcomes makes direct comparison difficult, although there is no
clear difference in terms of cost-effectiveness between shorter and
longer interventions. Only five studies consider both longer and
shorter interventions. Two of these (13, 14) report that the longer
intervention is cost-effective relative to the shorter one, although
this conclusion is difficult to make on the basis of the analysis
presented in the studies, particularly given the short follow-up of
the trials. The other three studies (4, 28, 33) assume no difference
in effectiveness but find that longer, more expensive interventions
are still highly likely to be considered cost-effective compared to
no intervention.
In order to further explore the relationship between delivery
staff, BI duration, and cost-effectiveness, Figure 2 presents a direct
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FIGURE 2 | Cost-effectiveness of SBI programs by SBI duration and
delivery staff.
comparison of the cost-effectiveness results converted to 2013 UK
£, for those studies which report delivery staff, intervention dura-
tion, and an Incremental Cost–Effectiveness Ratio (ICER) (4, 13,
25, 26, 28, 33, 36).
DISCUSSION
This systematic review provides strong evidence that SBIs in a pri-
mary care setting are a cost-effective policy option for tackling
alcohol-related harms, at least in high-income countries. There is
a paucity of evidence for lower- or middle-income countries and
that does exist indicates that there may be substantial heterogene-
ity in both the expected costs and effectiveness of SBI programs
depending on the local context in these areas (30).
There is also substantial heterogeneity in study methods,
included costs, and reported health outcomes between the
included studies, which makes it difficult to determine the impli-
cations of this diverse body of evidence for those making resource
allocation decisions, although there is an apparent trend for more
recent studies to use standardized measures such as QALYs or
DALYs, which makes between-study comparison more meaning-
ful. There are also significant differences in the national contexts
between studies (for example the existing level of drinking or the
current suite of alcohol policies in the country), which must be
considered when making international comparisons.
Considering these differences, there is no clear evidence that
the choice of delivery staff for SBI programs has a substantial
impact on the program’s cost-effectiveness. This may be because
GP-delivered interventions are more effective but more costly than
those delivered by nurses, although this would be at odds with
existing literature, which suggests that the use of less costly nursing
staff to conduct tasks that would otherwise be the responsibility of
GPs is unlikely to impact negatively on the quality of care received
by patients (37, 38). Figure 2 also suggests that nurses may be a
more cost-effective option, although heterogeneity in settings and
methods between the included studies mean that the graph should
be interpreted with caution.
It is also important to note that policy makers will need to con-
sider the total budget impact of any policy options in addition to
the potential cost-effectiveness, an issue highlighted in several of
the included studies (28, 33, 39). This may suggest that nurse-led
SBI programs, which are likely to be less costly overall, may be
more appealing option, although consideration must be given to
the existing primary care systems in each country. For example,
in countries such as the UK or the Netherlands where practice
nurses already undertake many primary care services such as vac-
cinations or health checks, nurse-led SBIs may be a more practical
option than in other countries where care is currently delivered
exclusively by the GP.
There is also no clear evidence that the duration of intervention
delivered has a substantial impact on cost-effectiveness. Again this
may indicate that longer interventions are more effective but more
expensive, although studies on the effectiveness evidence have not
found a consistent relationship between amount of patient con-
tact and effectiveness (5, 40). While the studies by Watson and
Drummond provide limited evidence that longer interventions
may be more cost-effective in the short-term in the UK context,
it is not clear that this translates to the longer term, or to other
countries (13, 14).
In addition to the substantial heterogeneity between studies
already mentioned, there are a number of limitations to this sys-
tematic review. Only studies published in the English language
were included, something which may be at least partly responsible
for the lack of included studies from the developing world. Some of
the included studies are also of low methodological quality which
makes it difficult to evaluate the robustness of their conclusions.
Finally, there are two key issues, which no study of SBI effectiveness
can escape. The first is that the estimates of effectiveness, which
underpin the cost-effectiveness estimates examined here may be
exaggerated by the impact of regression to the mean, caused by
drinkers changing their consumption over time for reasons unre-
lated to the receipt of a brief intervention (e.g., public holidays
or seasonal variation) (41). The second, countervailing issue is
that of an intervention or Hawthorne effect, whereby the act of
being enrolled into a trial acts as an intervention in itself, some-
thing which may at least partly explain why many SBI effectiveness
studies observe a reduction in alcohol consumption over time in
the control groups (42).
Limitations in the evidence base mean that this review is unable
to address a number of other issues that may be of interest to pol-
icy makers such as the cost-effectiveness of SBI programs targeting
specific groups within the general population. Further research to
examine the differential effectiveness of, and the likely coverage
by, SBI programs in these subgroups is important to allow this
area to be explored further. The other key priority for further
research to inform decision makers concerns the uptake among
primary care providers of SBI programs. Difficulties in persuad-
ing GPs and nurses to fully deliver SBI programs could have a
substantial impact on the effectiveness and cost-effectiveness of
these programs. A recent international trial conducted as part
of the optimizing delivery of healthcare interventions (ODHIN)
project will go some way to addressing this challenge by examin-
ing the effectiveness and cost-effectiveness of different strategies
at increasing SBI delivery rates in primary care (43).
In conclusion, while there are significant differences between
the studies included in this review, the overwhelming conclusion is
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that SBIs in primary care are a cost-effective option, at least in high-
income countries. There is no clear evidence that the duration of
the intervention, or the type of staff used to deliver it, changes
this conclusion. Policy makers should, however, be mindful of
the differing budget implications that alternative implementation
options may present.
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